[go: up one dir, main page]

WO2001075020A3 - A novel polypeptide, a human neuropolypeptide y 11 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, a human neuropolypeptide y 11 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001075020A3
WO2001075020A3 PCT/CN2001/000358 CN0100358W WO0175020A3 WO 2001075020 A3 WO2001075020 A3 WO 2001075020A3 CN 0100358 W CN0100358 W CN 0100358W WO 0175020 A3 WO0175020 A3 WO 0175020A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
human
discloses
neuropolypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000358
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001075020A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU50256/01A priority Critical patent/AU5025601A/en
Publication of WO2001075020A2 publication Critical patent/WO2001075020A2/en
Publication of WO2001075020A3 publication Critical patent/WO2001075020A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention discloses a novel polypeptide, a human neuroprotein Y protein 11, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as neural diseases, various tumor, cardiovascular disease, development disturbance disease, inflammation, immunological disease, hemopathy, HIV infection etc. The invention also discloses the agonistes against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the novel human neuropolypeptide 11.
PCT/CN2001/000358 2000-03-22 2001-03-19 A novel polypeptide, a human neuropolypeptide y 11 and the polynucleotide encoding the polypeptide Ceased WO2001075020A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU50256/01A AU5025601A (en) 2000-03-22 2001-03-19 A novel polypeptide, human neuroprotein y 11 and the polynucleotide encoding thepolypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 00115045 CN1314397A (en) 2000-03-22 2000-03-22 New polypeptide-human nerve polypeptide Y protein 11 and polynucleotide for coding such polypeptide
CN00115045.6 2000-03-22

Publications (2)

Publication Number Publication Date
WO2001075020A2 WO2001075020A2 (en) 2001-10-11
WO2001075020A3 true WO2001075020A3 (en) 2002-06-13

Family

ID=4584516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000358 Ceased WO2001075020A2 (en) 2000-03-22 2001-03-19 A novel polypeptide, a human neuropolypeptide y 11 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1314397A (en)
AU (1) AU5025601A (en)
WO (1) WO2001075020A2 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOLLENGIER F. ET AL., J. NEUROCHEM., vol. 50, no. 4, April 1988 (1988-04-01), pages 1210 - 1214 *
SEDDIQI N. ET AL., J. MOL. EVOL., vol. 39, no. 6, December 1994 (1994-12-01), pages 655 - 660 *

Also Published As

Publication number Publication date
WO2001075020A2 (en) 2001-10-11
AU5025601A (en) 2001-10-15
CN1314397A (en) 2001-09-26

Similar Documents

Publication Publication Date Title
WO2001075020A3 (en) A novel polypeptide, a human neuropolypeptide y 11 and the polynucleotide encoding the polypeptide
WO2002000822A3 (en) A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2001075021A3 (en) A novel polypeptide, glucose transport-associated human protein 10 and the polynucleotide encoding the polypeptide
WO2001075054A3 (en) A novel polypeptide, microglobulin transcription human regulation factor 30 and the polynucleotide encoding the polypeptide
WO2001075053A3 (en) A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide
WO2001075024A3 (en) A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide
WO2001083685A3 (en) A novel polypeptide, a cap protein 10 and the polynucleotide encoding the polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2002008421A1 (en) A novel polypeptide, a human tumor necrosis factor receptor 21.45 and the polynucleotide encoding the polypeptide
WO2001079431A3 (en) A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide
WO2001079439A3 (en) A novel polypeptide, a human cannabinoid receptor protein 19 and the polynucleotide encoding the polypeptide
WO2001075062A3 (en) A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide
WO2001075039A3 (en) A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide
WO2002008422A1 (en) A novel polypeptide, a human myotube protein 10.56 and the polynucleotide encoding the polypeptide
WO2001075025A3 (en) A novel polypeptide, human thyroglobuline 9 and the polynuceotide encoding the polypeptide
WO2002000828A3 (en) A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide
WO2001075033A3 (en) A novel polypeptide, a human cell division cycle regulatory protein 9 and the polynucleotide encoding the polypeptide
WO2001075056A3 (en) A novel polypeptide, human light-chain clathrine 20 and the polynucleotide encoding the polypeptide
WO2001083682A3 (en) A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide
WO2001083687A3 (en) A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide
WO2002000821A3 (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide
WO2001075057A3 (en) A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP